Superdosagem de antidepressivo tricíclico

Referências

Principais artigos

Henry JA, Alexander CA, Sener EK. Relative mortality from overdose of antidepressants. BMJ. 1995;310:221-224.Texto completo  Resumo

Neimann JT, Bessen HA, Rothstein RJ, et al. Electrocardiographic criteria for tricyclic antidepressant cardiotoxicity. Am J Cardiol. 1986;57:1154-1159. Resumo

Body R, Bartram T, Azam F, et al. Guidelines in Emergency Medicine Network (GEMNet): guideline for the management of tricyclic antidepressant overdose. Emerg Med J. 2011;28:347-368. Resumo

Artigos de referência

1. Henry JA, Alexander CA, Sener EK. Relative mortality from overdose of antidepressants. BMJ. 1995;310:221-224.Texto completo  Resumo

2. Whyte IM, Dawson AH, Buckley NA. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. QJM. 2003;96:369-374.Texto completo  Resumo

3. Buckley NA, Dawson AH, Whyte IM, et al. Greater toxicity in overdose of dothiepin than of other tricyclic antidepressants. Lancet. 1994;343:159-162. Resumo

4. Pacher P, Ungvari Z. Selective serotonin-reuptake inhibitor antidepressants increase the risk of falls and hip fractures in elderly people by inhibiting cardiovascular ion channels. Med Hypotheses. 2001;57:469-471. Resumo

5. Tyrrell EG, Kendrick D, Sayal K, et al. Poisoning substances taken by young people: a population-based cohort study. Br J Gen Pract. 2018 Oct;68(675):e703-10.Texto completo  Resumo

6. Morgan OW, Griffiths C, Majeed A. Association between mortality from suicide in England and antidepressant prescribing: an ecological study. BMC Public Health 2004;4:63.Texto completo  Resumo

7. Gummin DD, Mowry JB, Spyker DA, et al. 2017 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 35th annual report. Clin Toxicol (Phila). 2018 Dec;56(12):1213-1415.Texto completo  Resumo

8. Stafford RS, MacDonald EA, Finkelstein SN. National patterns of medication treatment for depression, 1987 to 2001. Prim Care Companion J Clin Psychiatry. 2001 Dec;3(6):232-5.Texto completo  Resumo

9. Tamblyn R, Bates DW, Buckeridge DL, et al. Multinational comparison of new antidepressant use in older adults: a cohort study. BMJ Open. 2019 May 14;9(5):e027663.Texto completo  Resumo

10. Bachmann CJ, Aagaard L, Burcu M, et al. Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005-2012. Eur Neuropsychopharmacol. 2016 Mar;26(3):411-9. Resumo

11. Kerr GW, McGuffie AC, Wilkie S. Tricyclic antidepressant overdose: a review. Emerg Med J. 2001;18:236-241.Texto completo  Resumo

12. Barbey JT, Roose SP. SSRI safety in overdose. J Clin Psychiatry. 1998;59(suppl 15):42-48. Resumo

13. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112-1120. Resumo

14. DeBattista C. Antidepressant drugs. In: Trevor AJ, Katzung B, Masters S, eds. Basic and clinical pharmacology. 11th ed. New York, NY: Lange, McGraw-Hill Medical Publishing Division; 2009.

15. Grunebaum MF, Ellis SP, Li S, et al. Antidepressants and suicide risk in the United States, 1985-1999. J Clin Psychiatry. 2004;65:1456-1462. Resumo

16. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol. 1979;47:343-352. Resumo

17. Thanacoody HK, Thomas SH. Tricyclic antidepressant poisoning: cardiovascular toxicity. Toxicol Rev. 2005;24:205-214. Resumo

18. Neimann JT, Bessen HA, Rothstein RJ, et al. Electrocardiographic criteria for tricyclic antidepressant cardiotoxicity. Am J Cardiol. 1986;57:1154-1159. Resumo

19. Boehnert M, Lovejoy FH Jr. Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med. 1985;313:474-479. Resumo

20. Pentel P, Peterson CD. Asystole complicating physostigmine treatment of tricyclic antidepressant overdose. Ann Emerg Med. 1980;9:588-590. Resumo

21. Bradberry SM, Thanacoody HK, Watt BE, et al. Management of the cardiovascular complications of tricyclic antidepressant poisoning: role of sodium bicarbonate. Toxicol Rev. 2005;24:195-204. Resumo

22. Woolf AD, Erdman AR, Nelson LS, et al. Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2007;45:203-233. Resumo

23. Foulke GE. Identifying toxicity risk early after antidepressant overdose. Am J Emerg Med. 1995;13:123-126. Resumo

24. Caravati EM, Bossart PJ. Demographic and electrocardiographic factors associated with severe tricyclic antidepressant toxicity. J Toxicol Clin Toxicol. 1991;29:31-43. Resumo

25. Body R, Bartram T, Azam F, et al. Guidelines in Emergency Medicine Network (GEMNet): guideline for the management of tricyclic antidepressant overdose. Emerg Med J. 2011;28:347-368. Resumo

26. Emerman CL, Connors AF Jr, Burma GM. Level of consciousness as a predictor of complications following tricyclic overdose. Ann Emerg Med. 1987;16:326-330. Resumo

27. Callaham M, Kassel D. Epidemiology of fatal tricyclic antidepressant ingestion: implications for management. Ann Emerg Med. 1985;14:1-9. Resumo

28. Dargan PI, Colbridge MG, Jones AL. The management of tricyclic antidepressant poisoning: the role of gut decontamination, extracorporeal procedures and fab antibody fragments. Toxicol Rev. 2005;24:187-194. Resumo

29. Sasyniuk BI, Jhamandas V. Mechanism of reversal of toxic effects of amitriptyline on cardiac Purkinje fibers by sodium bicarbonate. J Pharmacol Exp Ther. 1984;231:387-394. Resumo

30. Sensky PR, Olczak SA. High-dose intravenous glucagon in severe tricyclic poisoning. Postgrad Med J. 1999;75:611-612.Texto completo  Resumo

31. Sener EK, Gabe S, Henry JA. Response to glucagon in imipramine overdose. J Toxicol Clin Toxicol. 1995;33:51-53. Resumo

32. Zuidema X, Dünser MW, Wenzel V, et al. Terlipressin as an adjunct vasopressor in refractory hypotension after tricyclic antidepressant intoxication. Resuscitation. 2007;72:319-323. Resumo

33. Barry JD, Durkovich DW, Williams SR. Vasopressin treatment for cyclic antidepressant overdose. J Emerg Med. 2006;31:65-68. Resumo

34. Williams JM, Hollingshed MJ, Vasilakis A, et al. Extracorporeal circulation in the management of severe tricyclic antidepressant overdose. Am J Emerg Med. 1994;12:456-458. Resumo

35. Goodwin DA, Lally KP, Null DM Jr. Extracorporeal membrane oxygenation support for cardiac dysfunction from tricyclic antidepressant overdose. Crit Care Med. 1993;21:625-627. Resumo

36. Knudsen K, Abrahamsson J. Magnesium sulphate in the treatment of ventricular fibrillation in amitriptyline poisoning. Eur Heart J. 1997;18:881-882.Texto completo  Resumo

37. Citak A, Soysal DD, Uçsel R, et al. Efficacy of long duration resuscitation and magnesium sulphate treatment in amitriptyline poisoning. Eur J Emerg Med. 2002;9:63-66. Resumo

38. Foianini A, Wiegand TJ, Benowitz N. What is the role of lidocaine or phenytoin in tricyclic antidepressant-induced cardiotoxicity? Clin Toxicol (Phila). 2010;48:325-330. Resumo

39. Cave G, Harvey M. Intravenous lipid emulsion as antidote beyond local anesthetic toxicity: a systematic review. Acad Emerg Med. 2009;16:815-824. Resumo

40. Cave G, Harvey M, Graudins A. Review article: intravenous lipid emulsion as antidote: a summary of published human experience. Emerg Med Australas. 2011;23:123-141.Texto completo  Resumo

41. Jamaty C, Bailey B, Larocque A, et al. Lipid emulsions in the treatment of acute poisoning: a systematic review of human and animal studies. Clin Toxicol (Phila). 2010;48:1-27. Resumo

42. Callaham M, Schumaker H, Pentel P. Phenytoin prophylaxis of cardiotoxicity in experimental amitriptyline poisoning. J Pharmacol Exp Ther. 1988;245:216-220. Resumo

43. Yalindağ-Oztürk N, Goto CS, Shepherd G, et al. A pilot pharmacokinetic study of tricyclic antidepressant ovine Fab for TCA poisoning in children. Clin Toxicol (Phila). 2010;48:418-423. Resumo

44. Heard K, Dart RC, Bogdan G, et al. A preliminary study of tricyclic antidepressant (TCA) ovine FAB for TCA toxicity. Clin Toxicol (Phila). 2006;44:275-281. Resumo

O uso deste conteúdo está sujeito ao nosso aviso legal